CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

被引：8

作者：

Turgeon, David ^{[1
]}

Bakowsky, Volodko ^{[2
]}

Baldwin, Corisande ^{[3
]}

Cabral, David A. ^{[4
]}

Clements-Baker, Marie ^{[5
]}

Clifford, Alison ^{[6
]}

Tervaert, Jan Willem Cohen ^{[6
]}

Dehghan, Natasha ^{[3
]}

Ennis, Daniel ^{[3
]}

Famorca, Leilani ^{[7
]}

Fifi-Mah, Aurore ^{[8
]}

Girard, Louis-Philippe ^{[9
]}

Lefebvre, Frederic ^{[10
]}

Liang, Patrick ^{[11
]}

Makhzoum, Jean-Paul ^{[12
]}

Massicotte-Azarniouch, David ^{[13
,14
]}

Mendel, Arielle ^{[15
]}

Milman, Nataliya ^{[16
]}

Reich, Heather N. ^{[17
]}

Robinson, David B. ^{[18
]}

Ross, Carolyn ^{[12
]}

Rumsey, Dax G. ^{[19
]}

Soowamber, Medha ^{[1
]}

Towheed, Tanveer E. ^{[5
]}

Trudeau, Judith ^{[20
]}

Twilt, Marinka ^{[21
]}

Yacyshyn, Elaine ^{[6
]}

Yardimci, Gozde K. ^{[1
]}

Khalidi, Nader ^{[7
]}

Barra, Lillian ^{[22
]}

Pagnoux, Christian ^{[1
]}

机构：

[1] Univ Toronto, Mt Sinai Hosp, Div Rheumatol, Vasculitis Clin, Toronto, ON, Canada

[2] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Div Rheumatol, Halifax, NS, Canada

[3] Univ British Columbia, Div Rheumatol, Vancouver, BC, Canada

[4] Univ British Columbia, BC Childrens Hosp, Div Pediat Rheumatol, Vancouver, BC, Canada

[5] Queens Univ, Div Rheumatol, Kingston, ON, Canada

[6] Univ Alberta, Div Rheumatol, Edmonton, AB, Canada

[7] McMaster Univ, Div Rheumatol, Hamilton, ON, Canada

[8] Univ Calgary, Div Rheumatol, Calgary, AB, Canada

[9] Univ Calgary, Div Nephrol, Calgary, AB, Canada

[10] Univ Montreal, Ctr Hosp Univ Montreal, Div Rheumatol, Montreal, PQ, Canada

[11] Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Div Rheumatol, Sherbrooke, PQ, Canada

[12] Univ Montreal, Hop Sacre Coeur Montreal, Div Internal Med, Montreal, PQ, Canada

[13] Univ Ottawa, Ottawa Hosp, Div Nephrol, Ottawa, ON, Canada

[14] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[15] McGill Univ, Div Rheumatol, Hlth Ctr, Montreal, PQ, Canada

[16] Univ Ottawa, Ottawa Hosp, Div Rheumatol, Ottawa, ON, Canada

[17] Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada

[18] Univ Manitoba, Div Rheumatol, Winnipeg, MB, Canada

[19] Univ Alberta, Dept Pediat, Div Pediat Rheumatol, Edmonton, AB, Canada

[20] Univ Laval, Div Rheumatol, CISSS Chaudiere Appalaches, Quebec City, PQ, Canada

[21] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Div Pediat Rheumatol, Calgary, AB, Canada

[22] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada

来源：

RHEUMATOLOGY | 2023年 / 62卷 / 08期

关键词：

ANCA; anti-neutrophil cytoplasm antibody-associated vasculitis; granulomatosis with polyangiitis; microscopic polyangiitis; glomerulonephritis; avacopan; ANCA-ASSOCIATED VASCULITIS; REMISSION INDUCTION; GLUCOCORTICOIDS; CYCLOPHOSPHAMIDE; MANAGEMENT; RITUXIMAB; MORTALITY; PROTECTS;

D O I：

10.1093/rheumatology/kead087

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective In 2020, the Canadian Vasculitis Research Network (CanVasc) published their updated recommendations for the management of ANCA-associated vasculitides (AAV). The current addendum provides further recommendations regarding the use of avacopan in AAV based on a review of newly available evidence. Methods An updated systematic literature review on avacopan (formerly, CCX168) using Medline, Embase, and the Cochrane Library was performed for publications up to September 2022. New recommendations were developed and categorized according to the EULAR grading levels, as done for previous CanVasc recommendations. A modified Delphi procedure and videoconferences were used to reach >= 80% consensus on the inclusion, wording and grading of each recommendation. Results Three new recommendations were developed. They focus on avacopan therapy indication and duration, as well as timely glucocorticoid tapering. Conclusion These 2022 addended recommendations provide rheumatologists, nephrologists and other specialists caring for patients with AAV with guidance for the use of avacopan, based on current evidence and consensus from Canadian experts.

引用

页码：2646 / 2651

页数：6

共 50 条

[1] CANVASC CONSENSUS RECOMMENDATIONS FOR THE USE OF AVACOPAN IN ANTINEUTROPHIL CYTOPLASM ANTIBODY-ASSOCIATED VASCULITIS: 2022 ADDENDUM
Turgeon, D.
Bakowsky, V.
Baldwin, C.
Cabral, D.
Clements-Baker, M.
Clifford, A.
Tervaert, J. W. Cohen
Dehghan, N.
Ennis, D.
Famorca, L.
Fifi-Mah, A.
Girard, L. P.
Lefebvre, F.
Liang, P.
Makhzoum, J. P.
Massicotte-Azarniouch, D.
Mendel, A.
Milman, N.
Reich, H.
Robinson, D.
Ross, C.
Rumsey, D. G.
Soowamber, M.
Towheed, T.
Trudeau, J.
Twilt, M.
Yacyshyn, E.
Yardimci, G.
Khalidi
Barra, L.
Pagnoux, C.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1609 - 1610
[2] CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update
Mendel, Arielle
Ennis, Daniel
Go, Ellen
Bakowsky, Volodko
Baldwin, Corisande
Benseler, Susanne M.
Cabral, David A.
Carette, Simon
Clements-Baker, Marie
Clifford, Alison H.
Tervaert, Jan Willem Cohen
Cox, Gerard
Dehghan, Natasha
Dipchand, Christine
Dhindsa, Navjot
Famorca, Leilani
Fifi-Mah, Aurore
Garner, Stephanie
Girard, Louis-Philippe
Lessard, Clode
Liang, Patrick
Noone, Damien
Makhzoum, Jean-Paul
Milman, Nataliya
Pineau, Christian A.
Reich, Heather N.
Rheaume, Maxime
Robinson, David B.
Rumsey, Dax G.
Towheed, Tanveer E.
Trudeau, Judith
Twilt, Marinka
Yacyshyn, Elaine
Yeung, Rae S. M.
Barra, Lillian B.
Khalidi, Nader
Pagnoux, Christian
JOURNAL OF RHEUMATOLOGY, 2021, 48 (04) : 555 - 566
[3] CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides
McGeoch, Lucy
Twilt, Marinka
Famorca, Leilani
Bakowsky, Volodko
Barra, Lillian
Benseler, Susan M.
Cabral, David A.
Carette, Simon
Cox, Gerald P.
Dhindsa, Navjot
Dipchand, Christine S.
Fifi-Mah, Aurore
Goulet, Michelle
Khalidi, Nader
Khraishi, Majed M.
Liang, Patrick
Milman, Nataliya
Pineau, Christian A.
Reich, Heather N.
Samadi, Nooshin
Shojania, Kam
Taylor-Gjevre, Regina
Towheed, Tanveer E.
Trudeau, Judith
Walsh, Michael
Yacyshyn, Elaine
Pagnoux, Christian
JOURNAL OF RHEUMATOLOGY, 2016, 43 (01) : 97 - 120
[4] EFFECTIVENESS ANALYSIS OF AVACOPAN IN ANTINEUTROPHIL CYTOPLASM ANTIBODY-ASSOCIATED VASCULITIS - A CANADIAN PERSPECTIVE
Lakhdari, K.
Vicente, C.
Melnyk, P.
Serna, Ramirez de Arellano A.
VALUE IN HEALTH, 2022, 25 (12) : S157 - S158
[5] Avacopan for antineutrophil cytoplasmic antibody-associated vasculitis
不详
AUSTRALIAN PRESCRIBER, 2024, 47 (05) : 158 - 159
[6] Antineutrophil cytoplasm antibody-associated vasculitis: recent developments
Furuta, Shunsuke
Jayne, David R. W.
KIDNEY INTERNATIONAL, 2013, 84 (02) : 244 - 249
[7] Emerging therapies in antineutrophil cytoplasm antibody-associated vasculitis
Furuta, Shunsuke
Jayne, David
CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (01) : 1 - 6
[8] Animal models of antineutrophil cytoplasm antibody-associated vasculitis
Salama, Alan D.
Little, Mark A.
CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (01) : 1 - 7
[9] Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis
Walsh, Michael
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (06): : 555 - 559
[10] Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
van Leeuwen, Jolijn R.
Bredewold, Obbo W.
van Dam, Laura S.
Werkman, Stella L.
Jonker, Jacqueline T.
Geelhoed, Miranda
Langeveld, Antonius P. M.
Remmelts, Hilde H. F.
van den Broecke, Maud M.
Ray, Argho
Rabelink, Ton J.
Teng, Y. K. Onno
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (03): : 624 - 628

← 1 2 3 4 5 →